DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Villanueva C, Albillos A, Genescà J. et al.
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre
trial.
Lancet 2019;
393: 1597-1608
DOI: 10.1016/S0140-6736(18)31875-0.
We do not assume any responsibility for the contents of the web pages of other providers.